Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newark, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CymaBay Therapeutics, Inc. has filed 780 SEC EDGAR filings since 19 Feb 2002

SEC filing history

Showing 576-600 of 768 matching filings.

Per page
25
Current page
24
4

FORM 4 -

Filing date
28 Apr 2016
Reporting date
26 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
28 Apr 2016
Reporting date
26 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A

FORM 3/A -

Filing date
28 Apr 2016
Reporting date
01 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36500

DEFA14A

Filing date
21 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36500

DEF 14A

Filing date
21 Apr 2016
Reporting date
02 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-87950

SC 13G

Filing date
20 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Apr 2016
Reporting date
15 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
19 Apr 2016
Reporting date
15 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
06 Apr 2016
Reporting date
04 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
01 Apr 2016
Reporting date
01 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
01 Apr 2016
Reporting date
01 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 -

Filing date
01 Apr 2016
Reporting date
01 Apr 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-210453

FORM S-8

Filing date
29 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
28 Mar 2016
Reporting date
25 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

8-K

Filing date
22 Mar 2016
Reporting date
19 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

SCHEDULE 13G/A, #2

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

CYMABAY THERAPEUTICS, INC.

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

CYMABAY THERAPEUTICS, INC.

Filing date
16 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

CYMABAY SCHEDULE 13GA 2-12-16

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

SC 13G/A

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

SC 13G/A

Filing date
10 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

SC 13G/A filing

Filing date
08 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-87950

13G FINAL ANNUAL FILING

Filing date
03 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36500

FORM 8-K

Filing date
29 Jan 2016
Reporting date
26 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .